Zhejiang Jingxin Pharmaceutical Co., Ltd. announced that at the Extraordinary General Meeting of 2022 held on 13 October 2022 elected Hu Wan as non-independent director, elected Zhang Daliang, Lei Ying and Xu Pan as independent directors.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.99 CNY | -2.14% | -1.43% | -13.60% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.60% | 1.33B | |
+43.43% | 749B | |
+39.42% | 605B | |
-6.48% | 351B | |
+19.45% | 328B | |
+8.74% | 292B | |
+11.92% | 216B | |
-2.62% | 214B | |
+0.40% | 167B | |
+6.72% | 165B |
- Stock Market
- Equities
- 002020 Stock
- News Zhejiang Jingxin Pharmaceutical Co., Ltd.
- Zhejiang Jingxin Pharmaceutical Co., Ltd. Announces Directorate Appointments